Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow

Stem Cells

Volumn 15, Issue 2, 1997, Pages 144-153

  Yamaguchi, Yasunori ^a,b   Tsumura, Haruhiko ^a   Miwa, Mitsuru ^b   Inaba, Kayo ^b  

^a KIRIN BREWERY CO LTD   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

B7 2; ICAM 1; Inhibition; Maturation; MHC class II; Stimulatory activity

Indexed keywords

CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; DENDRITIC CELL; FEMALE; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; STEM CELL; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0030893704     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150144     Document Type: Article

References (30)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
2. Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
3. Inaba K, Inaba M, Deguchi M et al. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA 1993;90:3038-3042.
4. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med 1995;182:1111-1119.
5. Caux C, Dezutter-Dambuyant C, Schmitt D et al. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-261.
6. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J Immunol 1995;154:5851-5861.
7. Koch F, Heufler C, Kampgen E et al. Tumor necrosis factor a maintains the viability of murine epidermal Langerhans cells in culture but in contrast to granulocyte/macrophage colony-stimulating factor, does not induce their functional maturation. J Exp Med 1990;171:159-171.
8. Chang CH, Furue M, Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur J Immunol 1995;25:394-398.
9. Grabbe S, Bruvers S, Granstein RD. Interleukin 1β but not transforming growth factor β inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Invest Dermatol 1994;102:67-73.
10. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor α (TNF-α). J Invest Dermatol 1992;99:48S.
11. MacPherson GG, Jenkins CD, Stein MJ et al. Endotoxin-mediated dendritic cell release from the intestine: characterization of released dendritic cells and TNF-dependence. J Immunol 1995;154:1317-1322.
12. Roake JA, Rao AS, Morris PJ et al. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 1995;181:2237-2247.
13. Ellingsworth LR, Brennan JE, Fok K et al. Antibodies to the N-terminal portion of cartilage inducing factor-A and transforming growth factor β. J Biol Chem 1986;261:12362.
14. Hooper WC, Pruckler J, Jackson D et al. The synergistic effect of hemin and transforming growth factor-β on hemoglobin accumulation in HEL erythroleukemia cells. Leuk Res 1991;15:753-758.
15. Keller JR, Jacobsen SEW, Sill K et al. Stimulation of granulopoiesis by transforming growth factor β synergy with granulocyte/macrophage-colony-stimulating factor. Proc Natl Acad Sci USA 1991;88:7190-7194.
16. Demidem A, Taylor JR, Grammer S et al. Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis. J Invest Dermatol 1991;96:401-407.
17. Gruschwitz MS, Hornstein OP. Expression of transforming growth factor type beta on human epidermal dendritic cells. J Invest Dermatol 1992;99:114-116.
18. Chen-Woan M, Delaney CP, Fournier V et al. A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX-62. J Immunol Methods 1995;178:157-171.
19. Larsen CP, Ritchie SC, Pearson T et al. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992;176:1215-1220.
20. Larsen CP, Ritchie SC, Hendrix R et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994;152:5208-5219.
21. Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-1860.
22. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179:1109-1118.
23. Rhoades KL, Cai S, Golub S et al. Granulocyte-macrophage colony-stimulating factor and interleukin-4 differentially regulate the human tumor necrosis factor-α promoter region. Cell Immunol 1995;161:125-131.
24. Piacibello W, Ferrero D, Sanavio F et al. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. Exp Hematol 1991;19:1084-1089.
25. Fan K, Ruan Q, Sensenbrenner L et al. Transforming growth factor-β1 bifunctionally regulates murine macrophage proliferation. Blood 1992;79:1679-1685.
26. + hemopoietic progenitors. J lmmunol 1996;157:1499-1507.
27. Alleva DG, Walker TM, Eigert KD. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-β1 : contrasting effects on resting and activated macrophages. J Leukoc Biol 1995;57:919-928.
28. Maeda H, Kuwahara H, Ichimura Y et al. TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol 1995;155:4926-4932.
29. Kulkarni AB, Huh CG, Becker D et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-774.
30. Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.